Expanding our knowledge
of cell therapy manufacturing


Reliable partner for cell & gene therapy manufacturing

As a long-term manufacturing partner, we will strategically guide our business partners through every step of the cell therapy manufacturing chain. We offer full services covering GMP production of Advanced Therapy Medicinal Products including genetically modified and viral vectors. SCTbio leverages a decade of experience
in development of autologous cell-based products, product supply for clinical trials, GMP compliance for the full lifecycle of drug development, manufacturing, quality control, QA/QP release, storage and logistics services and process development services to deliver the highest quality collaboration for your CDMO needs. 

History of SCTbio

SCTbio was formed on July 1, 2021, and is a part of PPF Biotech network. The key company and personnel capabilities have been generated within SOTIO Group, during its more than 10 years of history of drug development and manufacturing. All of SOTIO’s cell and gene therapy GMP manufacturing capabilities have been outsourced to SCTbio, including our GMP manufacturing facility in Prague, Czech Republic. 

12  years

in cell and gene therapy field

2.000 sqm

facility area including 420sqm of GMP clean rooms 


reliable team members

Our Team

New FDA Guidance Impacts the CAR-T Industry

We will attend to ISCT 2024

May 29 – April 1, 2024 in Vancouver

We will attend to German Biotech Days

April 16 - April 17, 2024 in Berlin

We will attend to EMBT global conference

April 14- April 17, 2024 in Glasgow

We will attend to Cell & gene on the Med

April 09 - April 11, 2024 in Roma

SCTbio Brochure

SCTbio Your Reliable Partner for Cell & Gene Therapy GMP Manufacturing

SCTbio Brochure for Analytical Services

Check-out SCTbio full range of analytical capabilities!

Certificate of GMP Compliance

CIR Certification from the Government of France

Validation and Comparability of the BACTEC method & BD FX40 Device for Sterility Testing of CAR-T Drug Products: A Comprehensive Study

We will attend to Advanced Therapies Congress

March 19-20, 2024 in London

Validating BD BACTEC FX40 Method for CAR-T Sterility Testing


November 6 - November 8, 2023 in Munich Germany


October 24 - October 27, 2023 in Brussels, Belgium

SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation and Logistics Capabilities in Europe

Source: Press Release - Prague, Czech Republic and Vienna, Austria

Orgenesis Announces Collaboration Agreement with SCTbio for the Production of Lentivirus Vectors

Source: Press Release - Germantown, MD and Prague, Czech Republic

We attended ISCT

May 31- June 3, 2023 in Paris, France

We attended The American Society of Gene & Cell Therapy (ASGCT)

May 16-20iest, 2023 in Los Angeles, California, USA

We attended Cell & Gene Meeting on the Med

April 12-14th, 2023 in Barcelona, Spain

We attended 10th Gene Quantification Event

March 20-24th, 2023 in Weihenstephan, Germany

We attended Advanced Therapies Congress

March 14-15th, 2023 in London, UK

We attended the CAR-TCR Europe

February 21-23rd, 2023 in London, UK

We attended the Viral Vector Process Development Summit

January 31- February 2nd, 2023 in Boston, MA, US

We attended the Advanced Therapies Week

January 17-23rd, 2023 in Miami, Florida, US

We attended to Cell & Gene Therapy Manufacturing & Commercialization Europe 2022

December 6-8th, 2022 in Amsterdam, NL


October 20th, 2022 in Berlin, Germany

We attended to Cell & Gene on the Mesa

October 11-13th, 2022 in Carlsbad, CA

We attended to Nordic Life Sciences Days

September 28-29th, 2022 in Malmo, Sweden

We attended to 6th International Symposium on CAR T cells (CAR T Day)

September 7-9th, 2022 in Lille, France

We attended to Advanced Therapies Europe

August 31st - September 1st, 2022 in London, UK 

We attended the Advanced Therapies 2022 Congress

May 24-25, 2022 in London, UK

We attended the ASGCT 25th Annual Meeting

May 16-19, 2022 in Washington, D.C.

SCTbio Video

Take a tour of our GMP manufacturing facility in Prague.

Change of company name: SOTIO a.s. is now SCTbio a.s.

Company split

Ukázka článku - Media

Praesent nec arcu lorem. Nulla vitae malesuada nisl, nec laoreet enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

SOTIO Biotech logo
“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
SOTIO Biotech Inc.
“Auditing SCTbio revealed to us a company in which GMP culture is deeply rooted, the quality system is well structured, and GMP readiness is not just a marketing keyword thanks to the constant effort of SCTbio’s people, their expertise, their commitment, and their attention to quality.”
Laporte Euro
Worldwide map showing the locations of SCTbio’s 150 qualified and regularly monitored Apheresis Centres.